首页> 外国专利> EVALUATION OF THE POTENTIAL RISK OF DRUG TOXICITY OR SIDE-EFFECTS BASED ON QUANTITATIVE EXPRESSION OF ADAR EDITING ENZYMES AND 5HT2CR ISOFORMS

EVALUATION OF THE POTENTIAL RISK OF DRUG TOXICITY OR SIDE-EFFECTS BASED ON QUANTITATIVE EXPRESSION OF ADAR EDITING ENZYMES AND 5HT2CR ISOFORMS

机译:基于ADAR编辑酶和5HT2CR亚型定量表达的药物毒性或副作用的潜在风险评估

摘要

The present invention relates to in vitro methodsfor the determination of thepotential toxicity of test compounds.The invention also comprises in vitro methods for the selection oftherapeutical compounds useful for the treatment of pathologyrelated to an alteration of the mechanism of the mRNA editing of ADARdependent A to I mRNA editing of the serotonin 2Cre-ceptor (5HTR2C). Finally, the present invention is directed to the kits andtools for the implementation of these methods. Thein-vention is of special utility in the pharmaceutical industry for analysisof the toxicity profile or the screening of compoundsin-volved in drug development and/or in pharmaceutical compositions.
机译:本发明涉及体外测定方法。测试化合物的潜在毒性。本发明还包括体外方法,用于选择用于病理学治疗的治疗性化合物与ADAR的mRNA编辑机制的改变有关依赖性血清素2C的A至I mRNA编辑受体(5HTR2C)。最后,本发明涉及试剂盒和用于实现这些方法的工具。的本发明在制药行业具有特殊用途,可用于分析毒性概况或化合物筛选参与药物开发和/或药物组合物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号